From discovery R&D milligrams to clinical GMP kilograms
Icosagen Cell Factory is a specialized European mammalian protein drug discovery, development, and manufacturing expert. By early 2024, the company will operate its own, on site, state-of-the-art GMP manufacturing plant from 50-1000L bioreactor scale. With this, and dedicated project managers, our client partners can seamlessly transition their antibody and recombinant protein drug candidates from preclinical stage into Phase I/II clinical trials.
The brand-new facility is designed and constructed for high-throughput biologics GMP manufacturing. It will be outfitted with the latest single-use equipment for the production of bulk drug substance, housing QC & QA, cell banking, seed train, upstream and downstream suites.
SEAMLESS TRANSITION
SEAMLESS TRANSITION
From discovery to large scale production.
FAST in vivo APPROACH
FAST in vivo APPROACH
After immunization stage, biologically active antibodies with optimal physicochemical properties can be delivered as fast as 8 to 9 weeks.
IMMUNIZATION AGILITY
IMMUNIZATION AGILITY
Immunization of chickens with DNA, peptides, proteins or VLPs can be used to develop antibodies against hard-to-express proteins.
FLEXIBLE
FLEXIBLE
All identified sequences can be used for production of different immune molecules (bi-specifics, chimeras, antibody fragmens etc.)